Partner Michael Blau was quoted in a Targeted Oncology article, “As Practices Look to the Future, 2 Models for Next-Generation Management Companies Emerge,” about the business models of three next-generation physician practice management companies.
Blau, who moderated a breakout session on the three companies during the Association of Community Cancer Centers (ACCC) 45th Annual Meeting & Cancer Center Business Center Summit in Washington, D.C., said it is important for community oncology practices to consider their position in the marketplace going forward. “One option for the oncology group to consider is a relationship with some type of next-generation practice management company,” he said.
By working with a next-generation practice management company, Blau said, the practice would gain access to new technology platforms, payer contracting and positioning for value-based care, and other operational/outcome improvements. Such a relationship could also assist with group purchasing, shared services, drug formularies, and more, he added.
Blau, who moderated a breakout session on the three companies during the Association of Community Cancer Centers (ACCC) 45th Annual Meeting & Cancer Center Business Center Summit in Washington, D.C., said it is important for community oncology practices to consider their position in the marketplace going forward. “One option for the oncology group to consider is a relationship with some type of next-generation practice management company,” he said.
By working with a next-generation practice management company, Blau said, the practice would gain access to new technology platforms, payer contracting and positioning for value-based care, and other operational/outcome improvements. Such a relationship could also assist with group purchasing, shared services, drug formularies, and more, he added.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”